Wednesday, September 30, 2020 5:51:52 AM
IMO-CEO knows exactly what he's doing.
It will get updated. Probably with
financials. I've seen several OTC companies
go back and forth, to and from, the yield sign.
IR- emailed me over a week ago and said
the QB,QX status is the objective.
I simply asked if they would get off the pinks
please. No demands.
My bet is we are waiting on "audited" financials.
I have a host of other theories related to other
actions. IMO - NONE are bad.
Sarbanes-Oxley accounting practices.
Great for ENRON, WORLDCOM but bad for
OTC. Evolved somewhat, but still
audit, review, final review. 3 separate firms.
Takes months. We should be progressing.
Consider that before you act.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM